Search research articles
Contact Us
Filters
Showing results (61-70 of 269) with videos related to
Page
of 27
Sort By:
Clinical Nephrology
|
October 30, 2019
Bartter syndrome type III with only a synonymous mutation of the <i>CLCNKB</i> gene
Yufang Xue, Bin Wang, Rining Tang, et al.
Renal Failure
|
June 15, 2016
Risk factors of acute kidney injury after acute myocardial infarction
Yan-Bei Sun, Bi-Cheng Liu, Yun Zou, et al.
Antioxidants & Redox Signaling
|
January 19, 2022
Disturbance of Hypoxia Response and Its Implications in Kidney Diseases
Zuo-Lin Li, Bin Wang, Yi Wen, et al.
Ebiomedicine
|
March 15, 2022
Hypoxia and chronic kidney disease
Bin Wang, Zuo-Lin Li, Yi-Lin Zhang, et al.
Chinese Medical Journal
|
April 28, 2004
Effect of irbesartan on angiotensin II-induced hypertrophy of human proximal tubular cells
Bi-Cheng Liu, Jing Sun, Qi Chen, et al.
The Journal of Pharmacy and Pharmacology
|
November 13, 2018
The PKCβ-p66shc-NADPH oxidase pathway plays a crucial role in diabetic nephropathy
Yu-Si Cheng, Jie Chao, Chen Chen, et al.
Acta Pharmacologica Sinica
|
July 27, 2006
Influence of connective tissue growth factor antisense oligonucleotide on angiotensin II-induced epithelial mesenchymal transition in HK2 cells
Long Chen, Bi-Cheng Liu, Xiao-Liang Zhang, et al.
American Journal of Nephrology
|
October 30, 2003
Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin II
Bi-Cheng Liu, Jing Sun, Qi Chen, et al.
Chinese Medical Journal
|
April 12, 2012
Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats
Hou-yong Dai, Min Zheng, Ri-ning Tang, et al.
Ebiomedicine
|
August 16, 2022
Cardiorenal protection of SGLT2 inhibitors-Perspectives from metabolic reprogramming
Yue-Ming Gao, Song-Tao Feng, Yi Wen, et al.
Page
of 27
Search research articles
Search
Showing results (61-70 of 269) with videos related to
Sort By:
Page
of 27
Clinical Nephrology
|
October 30, 2019
Bartter syndrome type III with only a synonymous mutation of the <i>CLCNKB</i> gene
Yufang Xue, Bin Wang, Rining Tang, et al.
Renal Failure
|
June 15, 2016
Risk factors of acute kidney injury after acute myocardial infarction
Yan-Bei Sun, Bi-Cheng Liu, Yun Zou, et al.
Antioxidants & Redox Signaling
|
January 19, 2022
Disturbance of Hypoxia Response and Its Implications in Kidney Diseases
Zuo-Lin Li, Bin Wang, Yi Wen, et al.
Ebiomedicine
|
March 15, 2022
Hypoxia and chronic kidney disease
Bin Wang, Zuo-Lin Li, Yi-Lin Zhang, et al.
Chinese Medical Journal
|
April 28, 2004
Effect of irbesartan on angiotensin II-induced hypertrophy of human proximal tubular cells
Bi-Cheng Liu, Jing Sun, Qi Chen, et al.
The Journal of Pharmacy and Pharmacology
|
November 13, 2018
The PKCβ-p66shc-NADPH oxidase pathway plays a crucial role in diabetic nephropathy
Yu-Si Cheng, Jie Chao, Chen Chen, et al.
Acta Pharmacologica Sinica
|
July 27, 2006
Influence of connective tissue growth factor antisense oligonucleotide on angiotensin II-induced epithelial mesenchymal transition in HK2 cells
Long Chen, Bi-Cheng Liu, Xiao-Liang Zhang, et al.
American Journal of Nephrology
|
October 30, 2003
Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin II
Bi-Cheng Liu, Jing Sun, Qi Chen, et al.
Chinese Medical Journal
|
April 12, 2012
Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats
Hou-yong Dai, Min Zheng, Ri-ning Tang, et al.
Ebiomedicine
|
August 16, 2022
Cardiorenal protection of SGLT2 inhibitors-Perspectives from metabolic reprogramming
Yue-Ming Gao, Song-Tao Feng, Yi Wen, et al.
Page
of 27